BUPROPION

BUPROPION was reported 99465 times

BUPROPION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EJECTION FRACTION 139 0.2392
1 SENSITISATION 180 0.2372
2 POSTMORTEM BLOOD DRUG LEVEL INCREASED 54 0.1448
3 SUSPECTED SUICIDE 673 0.1435
4 POLYCYSTIC OVARIES 177 0.1140
5 PERSISTENT GENITAL AROUSAL DISORDER 26 0.1121
6 ASTHMA EXERCISE INDUCED 33 0.0948
7 TEMPERATURE REGULATION DISORDER 203 0.0910
8 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 457 0.0891
9 RETINITIS 146 0.0844
10 FACTOR V LEIDEN MUTATION 33 0.0831
11 PSYCHIATRIC DECOMPENSATION 161 0.0823
12 OBSTRUCTIVE SLEEP APNOEA SYNDROME 98 0.0672
13 EJECTION FRACTION ABNORMAL 76 0.0620
14 DRUG SPECIFIC ANTIBODY 84 0.0613
15 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 40 0.0599
16 LUPUS VULGARIS 73 0.0579
17 NEPHRECTOMY 86 0.0579
18 COMPLETED SUICIDE 4617 0.0553
19 SEROTONIN SYNDROME 894 0.0465
20 FOETAL DEATH 237 0.0457
21 OESOPHAGEAL SPASM 84 0.0456
22 RHINITIS ALLERGIC 194 0.0435
23 DEPRESSIVE SYMPTOM 152 0.0431
24 GRANULOMA SKIN 35 0.0426
25 BRUGADA SYNDROME 44 0.0425
26 PSYCHOMOTOR SKILLS IMPAIRED 107 0.0408
27 FOOD ALLERGY 308 0.0399
28 BONE EROSION 137 0.0387
29 AREFLEXIA 103 0.0385
30 RHEUMATOID FACTOR POSITIVE 222 0.0384
31 DISTRIBUTIVE SHOCK 83 0.0366
32 PUPIL FIXED 63 0.0363
33 HYPERREFLEXIA 121 0.0347
34 DEPRESSION SUICIDAL 117 0.0338
35 BEZOAR 45 0.0326
36 REBOUND ACID HYPERSECRETION 96 0.0317
37 HALLUCINATIONS, MIXED 133 0.0316
38 EXPOSURE VIA INGESTION 79 0.0313
39 PULSELESS ELECTRICAL ACTIVITY 130 0.0311
40 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 32 0.0301
41 CLONUS 80 0.0292
42 CARDIOGENIC SHOCK 418 0.0291
43 VASOPLEGIA SYNDROME 47 0.0286
44 BONE DEMINERALISATION 30 0.0283
45 TEARFULNESS 120 0.0279
46 STATUS EPILEPTICUS 314 0.0278
47 CEREBRAL VENOUS THROMBOSIS 50 0.0275
48 GENERALISED TONIC-CLONIC SEIZURE 447 0.0270
49 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 176 0.0259
50 NEPHROGENIC ANAEMIA 119 0.0257
51 ADJUSTMENT DISORDER 33 0.0254
52 BLOOD PARATHYROID HORMONE DECREASED 36 0.0243
53 LABELLED DRUG-DRUG INTERACTION ISSUE 35 0.0242
54 INTENTIONAL OVERDOSE 1542 0.0240
55 ENDOMETRIOSIS 113 0.0237
56 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 46 0.0233
57 ACCIDENTAL DEATH 43 0.0231
58 ACUTE LUNG INJURY 27 0.0228
59 OESOPHAGEAL PAIN 90 0.0228
60 RED BLOOD CELL SEDIMENTATION RATE INCREASED 251 0.0227
61 TOXICITY TO VARIOUS AGENTS 3738 0.0221
62 HYPERPARATHYROIDISM SECONDARY 55 0.0219
63 LYMPHOEDEMA 150 0.0217
64 IMMUNODEFICIENCY 322 0.0216
65 PUPILLARY REFLEX IMPAIRED 39 0.0210
66 CARDIO-RESPIRATORY ARREST 866 0.0207
67 MYOCLONUS 244 0.0204
68 ACCIDENTAL POISONING 28 0.0204
69 PSYCHOMOTOR RETARDATION 57 0.0203
70 LUPUS-LIKE SYNDROME 180 0.0198
71 WOUND COMPLICATION 68 0.0198
72 FIBROMYALGIA 475 0.0195
73 ELECTROCARDIOGRAM QT PROLONGED 694 0.0193
74 PRESCRIBED OVERDOSE 372 0.0192
75 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 137 0.0191
76 BRAIN DEATH 59 0.0191
77 EXOSTOSIS 173 0.0189
78 RHEUMATOID NODULE 51 0.0185
79 SLEEP APNOEA SYNDROME 351 0.0184
80 GASTROINTESTINAL HYPOMOTILITY 41 0.0182
81 HYPERSEXUALITY 33 0.0180
82 SINUS TACHYCARDIA 256 0.0180
83 RESPIRATORY ARREST 474 0.0172
84 EXPOSURE TO TOXIC AGENT 55 0.0172
85 MAJOR DEPRESSION 125 0.0171
86 FOOT DEFORMITY 186 0.0168
87 SUBSTANCE USE 26 0.0167
88 POISONING 208 0.0165
89 SYNOVITIS 295 0.0163
90 MYDRIASIS 208 0.0162
91 COELIAC DISEASE 159 0.0162
92 IMPULSE-CONTROL DISORDER 33 0.0160
93 JOINT DISLOCATION 168 0.0159
94 CONTRAINDICATED PRODUCT ADMINISTERED 474 0.0156
95 CARPAL TUNNEL SYNDROME 219 0.0156
96 AUTONOMIC NERVOUS SYSTEM IMBALANCE 44 0.0150
97 RHEUMATIC FEVER 67 0.0150
98 SEIZURE 1733 0.0150
99 THERMAL BURN 106 0.0149
100 SWOLLEN JOINT COUNT INCREASED 47 0.0147
101 DRUG TOLERANCE DECREASED 41 0.0146
102 PANNICULITIS 35 0.0145
103 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 243 0.0143
104 GAMBLING DISORDER 38 0.0141
105 SLOW SPEECH 34 0.0140
106 SUBSTANCE ABUSE 114 0.0140
107 BURSITIS 169 0.0139
108 VENTRICULAR TACHYCARDIA 229 0.0139
109 LIBIDO INCREASED 28 0.0138
110 HAEMODYNAMIC INSTABILITY 105 0.0138
111 CHRONIC KIDNEY DISEASE 1044 0.0137
112 BLOOD TEST ABNORMAL 192 0.0137
113 WHITE BLOOD CELL COUNT ABNORMAL 87 0.0136
114 HYPOMANIA 50 0.0136
115 CARDIOTOXICITY 121 0.0136
116 VENTRICULAR HYPOKINESIA 43 0.0134
117 SUICIDE ATTEMPT 797 0.0131
118 TORSADE DE POINTES 103 0.0131
119 SPUTUM DISCOLOURED 123 0.0130
120 FINE MOTOR SKILL DYSFUNCTION 37 0.0128
121 BRAIN INJURY 128 0.0128
122 METHAEMOGLOBINAEMIA 29 0.0125
123 POTENTIATING DRUG INTERACTION 42 0.0125
124 FULL BLOOD COUNT ABNORMAL 132 0.0125
125 CARDIAC ARREST 1026 0.0124
126 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 208 0.0121
127 VENTRICULAR ARRHYTHMIA 44 0.0120
128 PEMPHIGUS 150 0.0120
129 RESPIRATORY ACIDOSIS 47 0.0119
130 HAND DEFORMITY 155 0.0118
131 ELECTRIC SHOCK SENSATION 33 0.0118
132 IMPAIRED GASTRIC EMPTYING 160 0.0117
133 COMA SCALE ABNORMAL 34 0.0117
134 PARANOIA 199 0.0115
135 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 545 0.0113
136 WOUND 315 0.0113
137 DRUG TITRATION ERROR 29 0.0112
138 COMPARTMENT SYNDROME 29 0.0111
139 DRUG INTERACTION 1752 0.0110
140 BLOOD LACTIC ACID INCREASED 57 0.0108
141 DUODENAL ULCER PERFORATION 80 0.0107
142 HYPERTONIC BLADDER 31 0.0107
143 MENTAL STATUS CHANGES 294 0.0106
144 DRUG ABUSE 873 0.0105
145 END STAGE RENAL DISEASE 189 0.0104
146 HALLUCINATION, VISUAL 216 0.0102
147 HALLUCINATION, AUDITORY 162 0.0102
148 DECREASED INTEREST 60 0.0102
149 DISSOCIATION 78 0.0102
150 HYPERCHOLESTEROLAEMIA 98 0.0101
151 PERICARDITIS 169 0.0100
152 VENTRICULAR DYSFUNCTION 26 0.0100
153 HYPERTHERMIA 76 0.0099
154 ENCEPHALOPATHY 244 0.0099
155 DEPRESSION 2255 0.0099
156 BUNDLE BRANCH BLOCK LEFT 42 0.0099
157 FEELING OF DESPAIR 45 0.0096
158 BRADYPHRENIA 63 0.0096
159 BLOOD SODIUM INCREASED 26 0.0096
160 UNRESPONSIVE TO STIMULI 246 0.0095
161 TACHYPHRENIA 33 0.0095
162 ANHEDONIA 250 0.0095
163 SUICIDAL IDEATION 870 0.0095
164 RESPIRATORY DEPRESSION 116 0.0095
165 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 61 0.0094
166 OBSESSIVE-COMPULSIVE DISORDER 75 0.0093
167 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 664 0.0093
168 METABOLIC ENCEPHALOPATHY 28 0.0093
169 AGITATION 685 0.0093
170 GESTATIONAL DIABETES 44 0.0092
171 OBESITY 145 0.0091
172 OVERDOSE 1962 0.0091
173 GASTROINTESTINAL SOUNDS ABNORMAL 45 0.0091
174 INFUSION RELATED REACTION 600 0.0090
175 EXPOSURE VIA BREAST MILK 36 0.0090
176 HEPATIC ENZYME INCREASED 612 0.0090
177 IMMUNE THROMBOCYTOPENIA 41 0.0089
178 HEPATIC CIRRHOSIS 165 0.0088
179 NASAL POLYPS 43 0.0087
180 DRUG INTOLERANCE 843 0.0087
181 PSYCHOTIC DISORDER 254 0.0086
182 BREATH SOUNDS ABNORMAL 42 0.0085
183 EXPOSURE DURING PREGNANCY 520 0.0084
184 HYPOTHYROIDISM 266 0.0083
185 FLANK PAIN 78 0.0083
186 BIPOLAR DISORDER 90 0.0083
187 SEXUAL DYSFUNCTION 96 0.0082
188 NYSTAGMUS 43 0.0081
189 TACHYCARDIA 717 0.0081
190 PRODUCT SUBSTITUTION ISSUE 459 0.0080
191 FLUID RETENTION 400 0.0079
192 PARKINSONISM 75 0.0077
193 JOINT STIFFNESS 200 0.0076
194 MACULOPATHY 27 0.0076
195 HELICOBACTER INFECTION 78 0.0076
196 INTENTIONAL SELF-INJURY 153 0.0076
197 VENTRICULAR FIBRILLATION 84 0.0076
198 THERAPEUTIC PRODUCT EFFECT DECREASED 338 0.0075
199 TREATMENT FAILURE 624 0.0075
200 MUSCLE RIGIDITY 90 0.0075
201 MANIA 123 0.0075
202 RENAL INJURY 222 0.0075
203 DEPRESSED LEVEL OF CONSCIOUSNESS 295 0.0074
204 EAR INFECTION 198 0.0074
205 INTENTIONAL PRODUCT MISUSE 651 0.0074
206 ECONOMIC PROBLEM 112 0.0074
207 GLOSSODYNIA 165 0.0074
208 RESTLESS LEGS SYNDROME 134 0.0074
209 SEDATION 191 0.0073
210 NEPHROPATHY 68 0.0073
211 PARTIAL SEIZURES 38 0.0072
212 OSTEOPENIA 109 0.0072
213 AKATHISIA 98 0.0072
214 SELF-INJURIOUS IDEATION 30 0.0071
215 HALLUCINATION 538 0.0071
216 SKIN NECROSIS 37 0.0071
217 ASTHMA 806 0.0071
218 UPPER RESPIRATORY TRACT INFECTION 327 0.0071
219 EJECTION FRACTION DECREASED 109 0.0070
220 C-REACTIVE PROTEIN INCREASED 255 0.0070
221 METABOLIC ACIDOSIS 224 0.0070
222 HYPERTONIA 40 0.0070
223 CARDIOPULMONARY FAILURE 27 0.0069
224 TOXIC ENCEPHALOPATHY 35 0.0069
225 OSTEOPOROSIS 281 0.0068
226 SCREAMING 43 0.0067
227 PANIC DISORDER 26 0.0067
228 OVERWEIGHT 36 0.0067
229 SUPRAVENTRICULAR TACHYCARDIA 64 0.0067
230 CYSTITIS 212 0.0067
231 SMALL FOR DATES BABY 33 0.0066
232 DECREASED IMMUNE RESPONSIVENESS 65 0.0066
233 OSTEOARTHRITIS 280 0.0066
234 LOSS OF LIBIDO 59 0.0066
235 SKIN ABRASION 31 0.0066
236 ACIDOSIS 50 0.0065
237 HYPERHIDROSIS 841 0.0065
238 SINUS BRADYCARDIA 63 0.0065
239 TENSION HEADACHE 28 0.0065
240 BRADYCARDIA 343 0.0065
241 DEPRESSED MOOD 341 0.0064
242 APATHY 92 0.0063
243 BRUXISM 34 0.0063
244 HYPERTENSION 1332 0.0063
245 CATATONIA 33 0.0063
246 POST-TRAUMATIC STRESS DISORDER 42 0.0063
247 PSYCHOMOTOR HYPERACTIVITY 104 0.0063
248 ANXIETY 1773 0.0062
249 THINKING ABNORMAL 115 0.0062
250 BLOOD PRESSURE SYSTOLIC DECREASED 28 0.0061
251 ARTHRITIS 484 0.0061
252 RHEUMATOID ARTHRITIS 696 0.0061
253 DELUSION 95 0.0061
254 BUNDLE BRANCH BLOCK RIGHT 28 0.0061
255 RENAL DISORDER 284 0.0061
256 GASTROOESOPHAGEAL REFLUX DISEASE 490 0.0061
257 ALCOHOLISM 26 0.0061
258 THERAPY NON-RESPONDER 271 0.0060
259 PSYCHOLOGICAL TRAUMA 52 0.0060
260 WITHDRAWAL SYNDROME 252 0.0060
261 NEUROLEPTIC MALIGNANT SYNDROME 71 0.0060
262 EUPHORIC MOOD 61 0.0059
263 HAIR DISORDER 49 0.0059
264 SOMNAMBULISM 39 0.0059
265 DYSPHEMIA 26 0.0059
266 BRAIN FOG 92 0.0059
267 TUBULOINTERSTITIAL NEPHRITIS 110 0.0059
268 PSORIATIC ARTHROPATHY 236 0.0058
269 DRUG LEVEL INCREASED 96 0.0058
270 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 45 0.0058
271 JOINT SWELLING 697 0.0058
272 MIGRAINE 550 0.0058
273 DISEASE RECURRENCE 274 0.0058
274 TINNITUS 263 0.0057
275 RHINITIS 46 0.0057
276 EXTRA DOSE ADMINISTERED 231 0.0057
277 MUSCLE SPASTICITY 70 0.0057
278 BRONCHITIS 421 0.0057
279 PANIC ATTACK 205 0.0056
280 PRODUCT ODOUR ABNORMAL 58 0.0055
281 DRUG SPECIFIC ANTIBODY PRESENT 36 0.0055
282 DRUG TOLERANCE 28 0.0055
283 IMPAIRED QUALITY OF LIFE 79 0.0055
284 BURNING SENSATION 385 0.0055
285 HYPOVOLAEMIA 32 0.0055
286 WALKING AID USER 36 0.0055
287 ACUTE KIDNEY INJURY 831 0.0054
288 TREMOR 900 0.0054
289 INTENTIONAL PRODUCT USE ISSUE 472 0.0054
290 THERAPEUTIC RESPONSE CHANGED 34 0.0054
291 LEUKOCYTOSIS 97 0.0054
292 DROOLING 37 0.0054
293 SYSTEMIC LUPUS ERYTHEMATOSUS 190 0.0053
294 MUSCULOSKELETAL STIFFNESS 463 0.0053
295 CIRCULATORY COLLAPSE 90 0.0053
296 DELIRIUM 183 0.0053
297 IMPAIRED WORK ABILITY 112 0.0052
298 MULTIPLE FRACTURES 86 0.0052
299 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 46 0.0052
300 RENAL TUBULAR NECROSIS 51 0.0052
301 PRODUCT RESIDUE PRESENT 28 0.0052
302 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 32 0.0052
303 POOR QUALITY SLEEP 111 0.0052
304 HYPOTENSION 1033 0.0051
305 NEUROTOXICITY 90 0.0051
306 DISTURBANCE IN ATTENTION 277 0.0051
307 TIC 28 0.0051
308 INSURANCE ISSUE 78 0.0051
309 STAPHYLOCOCCAL INFECTION 168 0.0051
310 INFUSION SITE SWELLING 32 0.0051
311 COMA 242 0.0051
312 BALANCE DISORDER 439 0.0051
313 DISCOMFORT 309 0.0051
314 ANAL FISSURE 27 0.0050
315 MUSCLE TWITCHING 116 0.0050
316 ATRIAL SEPTAL DEFECT 42 0.0050
317 SYMPTOM RECURRENCE 30 0.0050
318 CEREBRAL DISORDER 37 0.0050
319 URINARY INCONTINENCE 148 0.0050
320 IRRITABILITY 299 0.0050
321 INTERVERTEBRAL DISC DEGENERATION 46 0.0050
322 WEIGHT FLUCTUATION 52 0.0050
323 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 27 0.0050
324 PULMONARY CONGESTION 65 0.0049
325 PSORIASIS 641 0.0049
326 APHTHOUS ULCER 38 0.0049
327 DENTAL CARIES 54 0.0049
328 PRODUCT ADMINISTRATION INTERRUPTED 38 0.0048
329 INABILITY TO AFFORD MEDICATION 48 0.0048
330 MADAROSIS 56 0.0048
331 HAIR COLOUR CHANGES 60 0.0048
332 PRODUCTIVE COUGH 230 0.0048
333 RASH ERYTHEMATOUS 230 0.0048
334 HYPOKINESIA 69 0.0047
335 APNOEA 37 0.0047
336 BRADYKINESIA 28 0.0047
337 HAEMATOCRIT DECREASED 94 0.0047
338 DYSARTHRIA 178 0.0047
339 MENISCUS INJURY 29 0.0047
340 AFFECTIVE DISORDER 37 0.0047
341 THERAPY CESSATION 241 0.0047
342 CRYING 170 0.0047
343 BRAIN OEDEMA 59 0.0047
344 PRE-EXISTING CONDITION IMPROVED 29 0.0046
345 MEMORY IMPAIRMENT 638 0.0046
346 HYPOXIA 163 0.0046
347 PRODUCT USE ISSUE 868 0.0046
348 RENAL FAILURE 612 0.0046
349 TREATMENT NONCOMPLIANCE 252 0.0046
350 DYSKINESIA 187 0.0046
351 MOBILITY DECREASED 330 0.0046
352 DISORIENTATION 181 0.0046
353 LIGAMENT SPRAIN 45 0.0045
354 C-REACTIVE PROTEIN ABNORMAL 29 0.0045
355 PRESCRIBED UNDERDOSE 90 0.0045
356 DRUG-INDUCED LIVER INJURY 141 0.0045
357 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 46 0.0045
358 MOOD ALTERED 122 0.0045
359 LETHARGY 257 0.0045
360 RESTLESSNESS 163 0.0044
361 TOOTH FRACTURE 49 0.0044
362 DRY MOUTH 359 0.0044
363 TACHYPNOEA 60 0.0044
364 MIDDLE INSOMNIA 82 0.0044
365 WHEEZING 260 0.0044
366 MICTURITION URGENCY 50 0.0044
367 APPETITE DISORDER 29 0.0044
368 NICOTINE DEPENDENCE 34 0.0044
369 PNEUMONIA ASPIRATION 109 0.0044
370 DECREASED ACTIVITY 47 0.0044
371 SLEEP DISORDER 307 0.0043
372 POOR VENOUS ACCESS 45 0.0043
373 CONDITION AGGRAVATED 1319 0.0043
374 HAIR TEXTURE ABNORMAL 58 0.0043
375 ANKLE FRACTURE 67 0.0043
376 SCIATICA 69 0.0043
377 RHABDOMYOLYSIS 180 0.0043
378 SHOCK 99 0.0043
379 COGNITIVE DISORDER 201 0.0043
380 ATAXIA 51 0.0043
381 HYPERSENSITIVITY 794 0.0043
382 THERAPY CHANGE 42 0.0043
383 ARTHROPATHY 237 0.0043
384 CONCUSSION 33 0.0043
385 DRUG WITHDRAWAL SYNDROME NEONATAL 63 0.0043
386 FEELING JITTERY 81 0.0042
387 DYSSTASIA 124 0.0042
388 SEASONAL ALLERGY 60 0.0042
389 HAND FRACTURE 30 0.0042
390 BASAL CELL CARCINOMA 66 0.0042
391 SMALL INTESTINAL OBSTRUCTION 52 0.0042
392 ANAL INCONTINENCE 38 0.0042
393 ARRHYTHMIA 200 0.0042
394 POISONING DELIBERATE 40 0.0042
395 NODULE 55 0.0042
396 URINARY RETENTION 140 0.0042
397 ACUTE RESPIRATORY DISTRESS SYNDROME 74 0.0042
398 BREAST MASS 28 0.0042
399 HYPERPROLACTINAEMIA 27 0.0042
400 TYPE 2 DIABETES MELLITUS 140 0.0042
401 LIVER INJURY 102 0.0042
402 SKIN LACERATION 45 0.0041
403 FOREIGN BODY IN REPRODUCTIVE TRACT 37 0.0041
404 RIB FRACTURE 85 0.0041
405 ADVERSE DRUG REACTION 371 0.0041
406 HYPERCALCAEMIA 51 0.0041
407 HEAD DISCOMFORT 73 0.0041
408 ASPIRATION 45 0.0041
409 VITAMIN D DECREASED 35 0.0041
410 INITIAL INSOMNIA 42 0.0041
411 MENTAL IMPAIRMENT 99 0.0041
412 INSOMNIA 1080 0.0041
413 DYSTONIA 78 0.0040
414 AUTOIMMUNE DISORDER 39 0.0040
415 POSTOPERATIVE WOUND INFECTION 27 0.0040
416 AGGRESSION 200 0.0040
417 ABNORMAL BEHAVIOUR 158 0.0040
418 SPINAL OSTEOARTHRITIS 35 0.0040
419 TEMPERATURE INTOLERANCE 41 0.0040
420 UTERINE LEIOMYOMA 29 0.0040
421 IRRITABLE BOWEL SYNDROME 85 0.0040
422 BACK INJURY 43 0.0040
423 DIVERTICULUM 28 0.0039
424 DRUG SCREEN POSITIVE 31 0.0039
425 HIP ARTHROPLASTY 60 0.0039
426 GLOMERULAR FILTRATION RATE DECREASED 48 0.0039
427 MATERNAL EXPOSURE DURING PREGNANCY 348 0.0039
428 FEELING DRUNK 29 0.0039
429 GRAND MAL CONVULSION 36 0.0039
430 BLOOD PRESSURE SYSTOLIC INCREASED 76 0.0039
431 ROTATOR CUFF SYNDROME 50 0.0039
432 SOMNOLENCE 783 0.0039
433 CONFUSIONAL STATE 628 0.0039
434 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
435 INFUSION SITE PAIN 50 0.0039
436 FORMICATION 27 0.0039
437 COVID-19 680 0.0039
438 CARDIOMYOPATHY 57 0.0039
439 APHASIA 116 0.0038
440 MYASTHENIA GRAVIS 31 0.0038
441 ULCER 61 0.0038
442 MULTIPLE ALLERGIES 30 0.0038
443 HEADACHE 2397 0.0038
444 INCREASED APPETITE 73 0.0038
445 MENTAL DISORDER 166 0.0038
446 AMNESIA 247 0.0038
447 TASTE DISORDER 77 0.0038
448 IMPAIRED DRIVING ABILITY 43 0.0038
449 FALL 1259 0.0038
450 PHARYNGEAL SWELLING 37 0.0038
451 WEIGHT INCREASED 846 0.0038
452 IMPAIRED HEALING 124 0.0038
453 WRIST FRACTURE 45 0.0038
454 OESOPHAGITIS 41 0.0037
455 AFFECT LABILITY 36 0.0037
456 MOTOR DYSFUNCTION 38 0.0037
457 BLADDER DISORDER 37 0.0037
458 TARDIVE DYSKINESIA 105 0.0037
459 COLITIS ISCHAEMIC 25 0.0037
460 KNEE ARTHROPLASTY 78 0.0037
461 ANGER 125 0.0037
462 INTENTIONAL UNDERDOSE 27 0.0037
463 LOSS OF CONSCIOUSNESS 473 0.0037
464 CONSTIPATION 802 0.0037
465 FATIGUE 2862 0.0037
466 GAIT DISTURBANCE 702 0.0037
467 GASTROENTERITIS VIRAL 66 0.0037
468 BLOOD TESTOSTERONE DECREASED 25 0.0037
469 PRODUCT PRESCRIBING ERROR 87 0.0036
470 HEPATIC STEATOSIS 68 0.0036
471 INTENTIONAL DOSE OMISSION 104 0.0036
472 TENDERNESS 38 0.0036
473 GRIP STRENGTH DECREASED 32 0.0036
474 SARS-COV-2 TEST POSITIVE 48 0.0036
475 HEAD INJURY 115 0.0036
476 FEELING ABNORMAL 870 0.0036
477 ILEUS 45 0.0036
478 DIPLOPIA 94 0.0036
479 HYPOTONIA 36 0.0036
480 SCRATCH 38 0.0036
481 EMOTIONAL DISORDER 111 0.0036
482 HUNGER 50 0.0036
483 QUALITY OF LIFE DECREASED 48 0.0036
484 PRODUCT DOSE OMISSION IN ERROR 101 0.0036
485 VENTRICULAR EXTRASYSTOLES 37 0.0036
486 JOINT INJURY 76 0.0036
487 HEAVY MENSTRUAL BLEEDING 32 0.0036
488 HOSPICE CARE 35 0.0035
489 CHOLELITHIASIS 116 0.0035
490 SENSITIVE SKIN 26 0.0035
491 EATING DISORDER 75 0.0035
492 UPPER-AIRWAY COUGH SYNDROME 29 0.0035
493 INFECTION 508 0.0035
494 ARTHROPOD BITE 26 0.0035
495 ORAL CANDIDIASIS 46 0.0035
496 SPINAL OPERATION 43 0.0035
497 MIOSIS 28 0.0035
498 MOOD SWINGS 111 0.0035
499 BLOOD MAGNESIUM DECREASED 30 0.0035
500 PARAESTHESIA ORAL 50 0.0035
501 ALTERED STATE OF CONSCIOUSNESS 75 0.0035
502 BLOOD POTASSIUM DECREASED 104 0.0035
503 BLOOD IRON DECREASED 41 0.0035
504 SINUSITIS 353 0.0034
505 ELECTROCARDIOGRAM ABNORMAL 27 0.0034
506 ERECTILE DYSFUNCTION 88 0.0034
507 RETCHING 73 0.0034
508 TROPONIN INCREASED 26 0.0034
509 DIZZINESS 1703 0.0034
510 CARDIAC DISORDER 319 0.0034
511 PAIN 2086 0.0034
512 ORTHOSTATIC HYPOTENSION 59 0.0034
513 SPINAL COMPRESSION FRACTURE 28 0.0034
514 SPINAL DISORDER 32 0.0034
515 PNEUMONIA 1093 0.0034
516 ABNORMAL DREAMS 93 0.0034
517 BLOOD CHOLESTEROL INCREASED 157 0.0034
518 STOMATITIS 204 0.0034
519 FACIAL PAIN 30 0.0034
520 HYPOAESTHESIA 502 0.0034
521 DYSPNOEA EXERTIONAL 126 0.0033
522 PULMONARY FIBROSIS 64 0.0033
523 PRODUCT USE IN UNAPPROVED INDICATION 826 0.0033
524 ALOPECIA 654 0.0033
525 SKIN FISSURES 65 0.0033
526 ROAD TRAFFIC ACCIDENT 139 0.0033
527 HIATUS HERNIA 43 0.0033
528 THERAPEUTIC RESPONSE SHORTENED 109 0.0033
529 VITAMIN D DEFICIENCY 32 0.0033
530 MUSCLE TIGHTNESS 53 0.0033
531 MUSCLE INJURY 27 0.0033
532 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 170 0.0033
533 ABDOMINAL PAIN UPPER 670 0.0033
534 PRESYNCOPE 79 0.0032
535 NEURALGIA 79 0.0032
536 HYPOPHAGIA 83 0.0032
537 ABORTION SPONTANEOUS 130 0.0032
538 EAR PAIN 63 0.0032
539 ABDOMINAL PAIN 752 0.0032
540 BLOOD CREATININE INCREASED 211 0.0032
541 GAIT INABILITY 107 0.0032
542 DIZZINESS POSTURAL 31 0.0032
543 HYPOAESTHESIA ORAL 48 0.0032
544 ABDOMINAL DISCOMFORT 534 0.0032
545 NIGHTMARE 110 0.0032
546 SKIN ULCER 82 0.0032
547 EMOTIONAL DISTRESS 384 0.0032
548 HEPATITIS 81 0.0032
549 NAUSEA 2496 0.0032
550 OBSTRUCTIVE AIRWAYS DISORDER 35 0.0031
551 LOCALISED INFECTION 76 0.0031
552 ATRIAL FLUTTER 25 0.0031
553 NASAL CONGESTION 184 0.0031
554 ORAL HERPES 61 0.0031
555 GASTROINTESTINAL INFECTION 28 0.0031
556 LOWER LIMB FRACTURE 60 0.0031
557 INFLAMMATION 161 0.0031
558 FOOT FRACTURE 59 0.0031
559 FREQUENT BOWEL MOVEMENTS 84 0.0031
560 HYPONATRAEMIA 173 0.0031
561 HYPERSOMNIA 88 0.0031
562 DECUBITUS ULCER 25 0.0031
563 NIGHT SWEATS 98 0.0030
564 ANKYLOSING SPONDYLITIS 40 0.0030
565 SINUS CONGESTION 41 0.0030
566 ACCIDENTAL OVERDOSE 111 0.0030
567 VISUAL IMPAIRMENT 374 0.0030
568 OROPHARYNGEAL PAIN 278 0.0030
569 ATELECTASIS 29 0.0030
570 VISION BLURRED 412 0.0030
571 BACK PAIN 697 0.0030
572 BLOOD PRESSURE FLUCTUATION 72 0.0030
573 GASTROINTESTINAL PAIN 33 0.0030
574 OXYGEN SATURATION DECREASED 168 0.0030
575 HEART RATE INCREASED 296 0.0030
576 CONTUSION 287 0.0030
577 SCAB 34 0.0030
578 ADVERSE EVENT 274 0.0030
579 MUSCULOSKELETAL CHEST PAIN 46 0.0030
580 BONE DENSITY DECREASED 93 0.0030
581 BODY TEMPERATURE DECREASED 29 0.0029
582 MASS 41 0.0029
583 DECREASED APPETITE 681 0.0029
584 SINUS DISORDER 58 0.0029
585 EMBEDDED DEVICE 29 0.0029
586 PHOTOPHOBIA 55 0.0029
587 EAR DISCOMFORT 30 0.0029
588 SPEECH DISORDER 153 0.0029
589 URINARY TRACT INFECTION 498 0.0029
590 RENAL IMPAIRMENT 245 0.0029
591 HEREDITARY ANGIOEDEMA 31 0.0029
592 TOOTH INFECTION 38 0.0029
593 DYSPEPSIA 283 0.0029
594 DERMATITIS ATOPIC 151 0.0029
595 FEEDING DISORDER 58 0.0029
596 OFF LABEL USE 2503 0.0029
597 DRUG INEFFECTIVE 3765 0.0029
598 BONE DISORDER 52 0.0029
599 HYPERLIPIDAEMIA 34 0.0028
600 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 156 0.0028
601 CENTRAL NERVOUS SYSTEM LESION 39 0.0028
602 EYE INFECTION 32 0.0028
603 DRUG ERUPTION 50 0.0028
604 ABSCESS 45 0.0028
605 PULMONARY MASS 42 0.0028
606 EPILEPSY 86 0.0028
607 NEPHROLITHIASIS 129 0.0028
608 URTICARIA 471 0.0028
609 ARTHRALGIA 1169 0.0028
610 FOETAL EXPOSURE DURING PREGNANCY 228 0.0028
611 RASH PRURITIC 152 0.0028
612 CELLULITIS 141 0.0028
613 SPINAL FRACTURE 56 0.0028
614 PERIPHERAL SWELLING 430 0.0028
615 VOMITING 1312 0.0028
616 GOUT 50 0.0028
617 NERVOUSNESS 145 0.0028
618 PHARYNGITIS STREPTOCOCCAL 30 0.0028
619 MALNUTRITION 31 0.0028
620 FOLLICULITIS 29 0.0028
621 INJURY 194 0.0028
622 INTESTINAL OBSTRUCTION 104 0.0028
623 THERAPY PARTIAL RESPONDER 43 0.0028
624 ILLNESS 283 0.0027
625 OEDEMA PERIPHERAL 334 0.0027
626 PRODUCT PHYSICAL ISSUE 55 0.0027
627 NOCTURIA 33 0.0027
628 HEMIPARESIS 46 0.0027
629 BLISTER 152 0.0027
630 BLOOD SODIUM DECREASED 51 0.0027
631 HIP FRACTURE 87 0.0027
632 THERAPEUTIC RESPONSE DECREASED 164 0.0027
633 CLOSTRIDIUM DIFFICILE INFECTION 59 0.0027
634 RASH 1178 0.0027
635 DRUG EFFECT LESS THAN EXPECTED 40 0.0027
636 NERVE INJURY 30 0.0027
637 TRANSIENT ISCHAEMIC ATTACK 91 0.0027
638 THERAPEUTIC RESPONSE UNEXPECTED 121 0.0027
639 JOINT RANGE OF MOTION DECREASED 36 0.0027
640 EYE PAIN 151 0.0027
641 NASOPHARYNGITIS 493 0.0027
642 SKIN INFECTION 30 0.0027
643 NECK PAIN 149 0.0027
644 RESPIRATORY FAILURE 194 0.0027
645 ACUTE RESPIRATORY FAILURE 51 0.0026
646 APHONIA 37 0.0026
647 KIDNEY INFECTION 52 0.0026
648 INCONTINENCE 28 0.0026
649 THERAPY INTERRUPTED 189 0.0026
650 FEAR 71 0.0026
651 ORAL PAIN 59 0.0026
652 SKIN HAEMORRHAGE 39 0.0026
653 DERMATITIS CONTACT 30 0.0026
654 THROAT IRRITATION 118 0.0026
655 VERTIGO 160 0.0026
656 GENERAL PHYSICAL HEALTH DETERIORATION 303 0.0026
657 TOOTH DISORDER 58 0.0026
658 INTERVERTEBRAL DISC PROTRUSION 57 0.0026
659 COUGH 731 0.0026
660 PRODUCT DOSE OMISSION 170 0.0026
661 ACCIDENTAL EXPOSURE TO PRODUCT 268 0.0026
662 COMPLICATION OF DEVICE REMOVAL 47 0.0026
663 PAIN IN EXTREMITY 766 0.0026
664 DIARRHOEA 1676 0.0026
665 PANCREATITIS 137 0.0026
666 MALAISE 1135 0.0026
667 ELECTROLYTE IMBALANCE 30 0.0026
668 OEDEMA 140 0.0026
669 RESPIRATORY TRACT CONGESTION 41 0.0026
670 DEHYDRATION 344 0.0026
671 ABDOMINAL DISTENSION 269 0.0026
672 LOWER RESPIRATORY TRACT INFECTION 117 0.0026
673 BLOOD CREATINE PHOSPHOKINASE INCREASED 74 0.0026
674 MUSCLE SPASMS 471 0.0026
675 REBOUND EFFECT 29 0.0026
676 DEAFNESS 67 0.0026
677 ASPARTATE AMINOTRANSFERASE INCREASED 136 0.0026
678 UPPER LIMB FRACTURE 51 0.0026
679 WOUND INFECTION 28 0.0026
680 MUSCULOSKELETAL DISCOMFORT 44 0.0026
681 MULTIPLE SCLEROSIS RELAPSE 175 0.0026
682 BODY TEMPERATURE INCREASED 52 0.0025
683 INFLUENZA 284 0.0025
684 INJECTION SITE MASS 94 0.0025
685 COVID-19 PNEUMONIA 30 0.0025
686 DRUG RESISTANCE 65 0.0025
687 BLOOD PRESSURE INCREASED 386 0.0025
688 COORDINATION ABNORMAL 35 0.0025
689 BLOOD COUNT ABNORMAL 38 0.0025
690 VIRAL INFECTION 83 0.0025
691 BLOOD TRIGLYCERIDES INCREASED 44 0.0025
692 GASTROINTESTINAL DISORDER 223 0.0025
693 HERNIA 48 0.0025
694 PULMONARY OEDEMA 111 0.0025
695 TRANSAMINASES INCREASED 55 0.0025
696 POLLAKIURIA 103 0.0025
697 WEIGHT DECREASED 689 0.0025
698 MULTIPLE SCLEROSIS 118 0.0025
699 GASTROENTERITIS 36 0.0025
700 CHOKING 48 0.0025
701 SCAR 42 0.0025
702 RENAL PAIN 26 0.0025
703 PROCEDURAL PAIN 68 0.0024
704 DYSGEUSIA 182 0.0024
705 DIABETES MELLITUS 186 0.0024
706 BREAST PAIN 26 0.0024
707 PRURITUS 936 0.0024
708 NERVOUS SYSTEM DISORDER 76 0.0024
709 RHINORRHOEA 157 0.0024
710 PRODUCT DOSE OMISSION ISSUE 711 0.0024
711 MUSCULOSKELETAL DISORDER 46 0.0024
712 EXTRAPYRAMIDAL DISORDER 60 0.0024
713 FISTULA 27 0.0024
714 POST PROCEDURAL COMPLICATION 46 0.0024
715 SECRETION DISCHARGE 30 0.0024
716 ASTHENIA 896 0.0024
717 SWELLING 223 0.0024
718 DYSPHAGIA 226 0.0024
719 FRACTURE 45 0.0024
720 TOOTHACHE 43 0.0024
721 PALPITATIONS 278 0.0024
722 DEMENTIA 66 0.0024
723 SURGERY 138 0.0024
724 DYSPNOEA 1330 0.0023
725 FLUSHING 238 0.0023
726 BODY HEIGHT DECREASED 25 0.0023
727 PHARYNGITIS 29 0.0023
728 PERIPHERAL COLDNESS 32 0.0023
729 DRUG WITHDRAWAL SYNDROME 204 0.0023
730 ACTIVITIES OF DAILY LIVING IMPAIRED 46 0.0023
731 LIMB INJURY 63 0.0023
732 SNEEZING 52 0.0023
733 BLOOD PRESSURE ABNORMAL 46 0.0023
734 CANDIDA INFECTION 39 0.0023
735 CONVULSION 132 0.0023
736 MOVEMENT DISORDER 74 0.0023
737 PLATELET COUNT INCREASED 30 0.0023
738 MITRAL VALVE INCOMPETENCE 26 0.0023
739 MUSCULAR WEAKNESS 261 0.0023
740 MULTIPLE ORGAN DYSFUNCTION SYNDROME 65 0.0023
741 PARAESTHESIA 361 0.0023
742 MYOCARDIAL ISCHAEMIA 26 0.0023
743 HEART RATE DECREASED 80 0.0023
744 INFLUENZA LIKE ILLNESS 187 0.0023
745 CHOLECYSTITIS 27 0.0023
746 HEART RATE IRREGULAR 51 0.0023
747 LACTIC ACIDOSIS 73 0.0023
748 TOOTH EXTRACTION 28 0.0022
749 LIVER FUNCTION TEST INCREASED 48 0.0022
750 CHILLS 262 0.0022
751 ALANINE AMINOTRANSFERASE INCREASED 137 0.0022
752 CHEST DISCOMFORT 228 0.0022
753 ERUCTATION 43 0.0022
754 FLATULENCE 126 0.0022
755 SPLENOMEGALY 26 0.0022
756 THROAT TIGHTNESS 60 0.0022
757 MYALGIA 377 0.0022
758 MUSCLE ATROPHY 28 0.0022
759 BEDRIDDEN 29 0.0022
760 DIVERTICULITIS 61 0.0022
761 ECZEMA 115 0.0022
762 PRODUCT AVAILABILITY ISSUE 50 0.0022
763 TENDONITIS 34 0.0022
764 WHITE BLOOD CELL COUNT INCREASED 84 0.0022
765 GENERALISED OEDEMA 27 0.0022
766 SWOLLEN TONGUE 68 0.0022
767 RED BLOOD CELL COUNT DECREASED 62 0.0022
768 LIMB DISCOMFORT 67 0.0022
769 DRY EYE 108 0.0022
770 NEUROPATHY PERIPHERAL 205 0.0022
771 BLOOD PRESSURE DECREASED 143 0.0022
772 RESPIRATORY TRACT INFECTION 56 0.0021
773 LUNG DISORDER 105 0.0021
774 PRODUCT TASTE ABNORMAL 29 0.0021
775 UVEITIS 29 0.0021
776 FEELING HOT 131 0.0021
777 ERYTHEMA 439 0.0021
778 HAEMOGLOBIN DECREASED 218 0.0021
779 ANAPHYLACTIC REACTION 117 0.0021
780 TENDON RUPTURE 26 0.0021
781 COLITIS ULCERATIVE 94 0.0021
782 COLD SWEAT 37 0.0021
783 OSTEOMYELITIS 38 0.0021
784 CYST 26 0.0021
785 ACCIDENT 25 0.0021
786 DYSURIA 77 0.0021
787 FEELING COLD 58 0.0021
788 THYROID DISORDER 32 0.0021
789 TOOTH LOSS 43 0.0021
790 HOT FLUSH 156 0.0021
791 PHOTOSENSITIVITY REACTION 34 0.0021
792 DERMATITIS 43 0.0021
793 EYE IRRITATION 118 0.0020
794 HAEMATOCHEZIA 113 0.0020
795 SEPSIS 228 0.0020
796 PYREXIA 707 0.0020
797 CARDIOMEGALY 25 0.0020
798 BLOOD UREA INCREASED 34 0.0020
799 BACK DISORDER 33 0.0020
800 NEEDLE ISSUE 59 0.0020
801 MUSCULOSKELETAL PAIN 106 0.0020
802 THIRST 36 0.0020
803 FUNGAL INFECTION 67 0.0020
804 CHEST PAIN 372 0.0020
805 INJECTION SITE REACTION 138 0.0020
806 SKIN LESION 55 0.0020
807 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 361 0.0020
808 DYSPHONIA 117 0.0020
809 UNEVALUABLE EVENT 151 0.0020
810 CHROMATURIA 45 0.0020
811 RESPIRATORY DISTRESS 55 0.0020
812 BACTERIAL INFECTION 37 0.0020
813 COLITIS 75 0.0020
814 HEPATOTOXICITY 44 0.0020
815 UNDERDOSE 144 0.0020
816 CORONARY ARTERY OCCLUSION 27 0.0020
817 CATARACT 117 0.0020
818 DYSMENORRHOEA 26 0.0020
819 RECTAL HAEMORRHAGE 84 0.0020
820 LACRIMATION INCREASED 59 0.0020
821 HOSPITALISATION 300 0.0020
822 SKIN CANCER 42 0.0019
823 HAEMORRHOIDS 38 0.0019
824 SENSORY DISTURBANCE 31 0.0019
825 INJECTION SITE BRUISING 154 0.0019
826 LIVER FUNCTION TEST ABNORMAL 56 0.0019
827 DEEP VEIN THROMBOSIS 125 0.0019
828 RASH MACULAR 67 0.0019
829 GALLBLADDER DISORDER 34 0.0019
830 SYNCOPE 190 0.0019
831 ABDOMINAL PAIN LOWER 48 0.0019
832 HERPES ZOSTER 109 0.0019
833 BLOOD URINE PRESENT 36 0.0019
834 FAECES DISCOLOURED 41 0.0019
835 ATRIAL FIBRILLATION 184 0.0019
836 THROMBOCYTOPENIA 211 0.0019
837 ADVERSE REACTION 25 0.0019
838 PELVIC PAIN 34 0.0019
839 HAEMOPTYSIS 52 0.0019
840 GASTRITIS 49 0.0019
841 COMPLICATION ASSOCIATED WITH DEVICE 27 0.0019
842 CEREBRAL INFARCTION 45 0.0018
843 PRODUCT USE COMPLAINT 29 0.0018
844 PRODUCT QUALITY ISSUE 250 0.0018
845 DRUG DOSE OMISSION 304 0.0018
846 GASTRIC DISORDER 63 0.0018
847 DRY SKIN 245 0.0018
848 DRUG TOXICITY 25 0.0018
849 INJECTION SITE PRURITUS 120 0.0018
850 PRODUCT DISPENSING ERROR 39 0.0018
851 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 46 0.0018
852 HAEMATOMA 46 0.0018
853 DEVICE ISSUE 159 0.0018
854 LIP SWELLING 59 0.0018
855 INTENTIONAL DRUG MISUSE 37 0.0018
856 PAIN IN JAW 50 0.0018
857 ILL-DEFINED DISORDER 107 0.0018
858 STEVENS-JOHNSON SYNDROME 39 0.0018
859 DRUG EFFECT DECREASED 94 0.0017
860 HAEMORRHAGE INTRACRANIAL 26 0.0017
861 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 351 0.0017
862 LABORATORY TEST ABNORMAL 51 0.0017
863 PALLOR 47 0.0017
864 ANOSMIA 25 0.0017
865 PULMONARY EMBOLISM 163 0.0017
866 SKIN DISORDER 57 0.0017
867 DRUG EFFECT INCOMPLETE 62 0.0017
868 RESPIRATORY DISORDER 51 0.0017
869 SKIN DISCOLOURATION 77 0.0017
870 ANGIOEDEMA 74 0.0017
871 INJECTION SITE URTICARIA 41 0.0017
872 LYMPHADENOPATHY 59 0.0017
873 BONE LOSS 25 0.0017
874 SWELLING FACE 108 0.0017
875 HAEMATEMESIS 42 0.0017
876 RASH PAPULAR 37 0.0016
877 DEVICE BREAKAGE 67 0.0016
878 INCORRECT DOSE ADMINISTERED 376 0.0016
879 PANCREATITIS ACUTE 37 0.0016
880 MEDICATION ERROR 91 0.0016
881 PAIN OF SKIN 44 0.0016
882 PRODUCT ADMINISTRATION ERROR 33 0.0016
883 SKIN EXFOLIATION 137 0.0016
884 COMPLICATION OF DEVICE INSERTION 32 0.0016
885 EYE PRURITUS 54 0.0016
886 HYPOKALAEMIA 74 0.0016
887 OCULAR HYPERAEMIA 76 0.0016
888 HYPERKALAEMIA 56 0.0016
889 INCORRECT ROUTE OF DRUG ADMINISTRATION 57 0.0016
890 GASTROINTESTINAL HAEMORRHAGE 133 0.0016
891 APPLICATION SITE PRURITUS 36 0.0016
892 DRUG PRESCRIBING ERROR 30 0.0016
893 ACUTE MYOCARDIAL INFARCTION 46 0.0016
894 HYPOACUSIS 67 0.0016
895 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
896 BLOOD POTASSIUM INCREASED 25 0.0015
897 AGEUSIA 38 0.0015
898 DISABILITY 30 0.0015
899 THROMBOSIS 122 0.0015
900 CONJUNCTIVITIS 28 0.0015
901 EYE SWELLING 56 0.0015
902 BONE PAIN 88 0.0015
903 MYOCARDIAL INFARCTION 262 0.0015
904 COAGULOPATHY 25 0.0015
905 PLEURAL EFFUSION 91 0.0015
906 EYE DISORDER 49 0.0015
907 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 106 0.0015
908 PULMONARY HYPERTENSION 31 0.0015
909 INCORRECT PRODUCT ADMINISTRATION DURATION 32 0.0015
910 CARDIAC FAILURE CONGESTIVE 118 0.0015
911 WHITE BLOOD CELL COUNT DECREASED 159 0.0015
912 BLOOD GLUCOSE ABNORMAL 27 0.0015
913 DRUG DEPENDENCE 234 0.0015
914 BLOOD ALKALINE PHOSPHATASE INCREASED 36 0.0014
915 DEVICE DISLOCATION 63 0.0014
916 SEPTIC SHOCK 63 0.0014
917 INJECTION SITE PAIN 443 0.0014
918 BLOOD BILIRUBIN INCREASED 39 0.0014
919 INJECTION SITE SWELLING 110 0.0014
920 HYPERGLYCAEMIA 52 0.0014
921 PRODUCT PRESCRIBING ISSUE 31 0.0014
922 PROTEINURIA 27 0.0014
923 ANAEMIA 269 0.0014
924 APPLICATION SITE PAIN 31 0.0014
925 EPISTAXIS 105 0.0014
926 INJECTION SITE ERYTHEMA 174 0.0014
927 PREMATURE BABY 42 0.0014
928 BLOOD GLUCOSE DECREASED 67 0.0014
929 FULL BLOOD COUNT DECREASED 28 0.0014
930 CEREBROVASCULAR ACCIDENT 234 0.0014
931 LEUKOPENIA 69 0.0014
932 ABASIA 34 0.0014
933 INCORRECT DOSE ADMINISTERED BY DEVICE 36 0.0014
934 BREAST CANCER 128 0.0014
935 INJECTION SITE RASH 42 0.0014
936 INTERNATIONAL NORMALISED RATIO INCREASED 39 0.0014
937 PLASMA CELL MYELOMA 53 0.0014
938 CORONARY ARTERY DISEASE 41 0.0014
939 GLYCOSYLATED HAEMOGLOBIN INCREASED 34 0.0013
940 LIVER DISORDER 58 0.0013
941 DEATH 1117 0.0013
942 HAEMORRHAGE 134 0.0013
943 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 37 0.0013
944 ASCITES 37 0.0013
945 ANGINA PECTORIS 36 0.0013
946 INJECTION SITE HAEMORRHAGE 98 0.0012
947 HAEMATURIA 42 0.0012
948 VISUAL ACUITY REDUCED 40 0.0012
949 PLATELET COUNT DECREASED 127 0.0012
950 VAGINAL HAEMORRHAGE 51 0.0012
951 DIABETIC KETOACIDOSIS 28 0.0012
952 MENSTRUATION IRREGULAR 31 0.0012
953 HYPOGLYCAEMIA 56 0.0012
954 EXPIRED PRODUCT ADMINISTERED 38 0.0011
955 CARDIAC FAILURE 88 0.0011
956 APPLICATION SITE ERYTHEMA 28 0.0011
957 PNEUMONITIS 29 0.0011
958 CARDIOVASCULAR DISORDER 27 0.0011
959 BLOOD GLUCOSE INCREASED 200 0.0011
960 ACNE 80 0.0011
961 FEMUR FRACTURE 32 0.0010
962 HEPATIC FAILURE 31 0.0010
963 SKIN IRRITATION 47 0.0010
964 DEVICE DELIVERY SYSTEM ISSUE 28 0.0010
965 WRONG TECHNIQUE IN DRUG USAGE PROCESS 37 0.0010
966 PRODUCT ADHESION ISSUE 36 0.0010
967 EXPOSURE VIA SKIN CONTACT 26 0.0010
968 DEVICE LEAKAGE 43 0.0010
969 DRUG ADMINISTRATION ERROR 30 0.0010
970 NO ADVERSE EVENT 177 0.0010
971 BLINDNESS 39 0.0010
972 DISEASE PROGRESSION 112 0.0009
973 DEVICE MALFUNCTION 65 0.0009
974 RENAL FAILURE ACUTE 39 0.0009
975 OSTEONECROSIS 30 0.0009
976 GYNAECOMASTIA 28 0.0009
977 INTERSTITIAL LUNG DISEASE 43 0.0009
978 DEVICE EXPULSION 57 0.0009
979 CEREBRAL HAEMORRHAGE 31 0.0009
980 NEUTROPHIL COUNT DECREASED 34 0.0008
981 NEOPLASM MALIGNANT 52 0.0008
982 LUNG NEOPLASM MALIGNANT 32 0.0008
983 SKIN BURNING SENSATION 54 0.0008
984 NEUTROPENIA 102 0.0007
985 FEBRILE NEUTROPENIA 49 0.0007
986 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 34 0.0007
987 DEVICE USE ERROR 25 0.0007
988 DRUG DOSE OMISSION BY DEVICE 53 0.0007
989 MALIGNANT NEOPLASM PROGRESSION 69 0.0007
990 PRODUCT STORAGE ERROR 56 0.0006
991 PANCYTOPENIA 31 0.0006
992 DEVICE DIFFICULT TO USE 27 0.0004
993 PROSTATE CANCER 26 0.0003